Fermenta Biotech informs about successful closure of inspection

06 Jul 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fermenta Biotech has informed that US FDA has issued an Establishment Inspection Report (EIR) for the Company’s manufacturing facility situated at Dahej, Gujarat, India with no observations as to any significant objectionable conditions, and the inspection has been successfully ‘closed’ by the US FDA.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

262.40 -8.65 (-3.19%)
09-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.10
Dr. Reddys Lab 1095.15
Cipla 1416.30
Lupin 1921.30
Zydus Lifesciences 844.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...